151 related articles for article (PubMed ID: 6454771)
21. Hyperglycemia during induction therapy for acute lymphoblastic leukemia is temporally linked to pegaspargase administration.
Pollock NI; Flamand Y; Zhu J; Millington K; Stevenson K; Silverman LB; Vrooman LM; Cohen LE
Pediatr Blood Cancer; 2022 Jul; 69(7):e29505. PubMed ID: 34931744
[TBL] [Abstract][Full Text] [Related]
22. Favorable remission induction rate with twice weekly doses of L-asparaginase.
Jaffe N; Traggis D; Das L; Frauenberger G; Hann HW; Kim BS; Bishop Y
Cancer Res; 1973 Jan; 33(1):1-4. PubMed ID: 4565907
[No Abstract] [Full Text] [Related]
23. L-asparaginase-induced hypocomplementemia in acute lymphocytic leukemia (ALL) of childhood.
Shapiro R; Kim Y; Michael AF; Gerrard JM; Nesbit M; Coccia P; Ramsay NK; Krivit W
Am J Pediatr Hematol Oncol; 1979; 1(1):5-7. PubMed ID: 295575
[TBL] [Abstract][Full Text] [Related]
24. Diabetes in patients treated with asparaginase.
Gailani S; Nussbaum A; Onuma T; Freeman A
Clin Pharmacol Ther; 1971; 12(3):487-90. PubMed ID: 5284834
[No Abstract] [Full Text] [Related]
25. Hyperglucagonemia in L-asparaginase induced diabetes mellitus.
Rao SP; Castells S
Am J Pediatr Hematol Oncol; 1986; 8(1):83-5. PubMed ID: 3521362
[No Abstract] [Full Text] [Related]
26. Attenuation of asparaginase-induced hyperglycemia after substitution of the Erwinia carotovora for the Escherichia coli enzyme preparation.
Ridgway D; Neerhout RC; Bleyer A
Cancer; 1989 Feb; 63(3):561-3. PubMed ID: 2643458
[TBL] [Abstract][Full Text] [Related]
27. [Acute diabetes during l-asparaginase treatment of acute leukosis].
Mallarme J; Chimènes H
Diabete; 1969; 17(2):95-8. PubMed ID: 5275053
[No Abstract] [Full Text] [Related]
28. [Attempts at treatment of acute leukemia with L-asparaginase].
Lawkowicz W; Krzemińska-Lawkowiczowa ; Kozlowska J; Polubiec A; Derulska D; Kolakowska-Polubiec K; Litwin J; Rokicka R
Acta Haematol Pol; 1971; 2(4):305-10. PubMed ID: 5293225
[No Abstract] [Full Text] [Related]
29. [Use of L-asparaginase in therapy with special reference to acute lymphatic leukemia].
Storti E; Fontana G
Minerva Med; 1972 Mar; 63(24):1445-56. PubMed ID: 4502507
[No Abstract] [Full Text] [Related]
30. [Letter: Acute lymphoid leukemia: constant induction of remission by the combination of prednisone, vincristine and L-asparaginase (20 cases)].
Mathe G; Pouillart P; De Vassal F; Delgado M; Schwarzenberg L; Misset JL; Hayat M; Jasmin C; Belpomme D; Musset M
Nouv Presse Med; 1976 Jun; 5(23):1491. PubMed ID: 1064849
[No Abstract] [Full Text] [Related]
31. Sequential changes in platelet function and coagulation in leukemic children treated with L-asparaginase, prednisone, and vincristine.
Pui CH; Jackson CW; Chesney C; Lyles SA; Bowman WP; Abromowitch M; Simone JV
J Clin Oncol; 1983 Jun; 1(6):380-5. PubMed ID: 6583320
[TBL] [Abstract][Full Text] [Related]
32. [Leukoencephalopathy in children with acute lymphocytic leukemia receiving preventive central nervous system therapy (author's transl)].
Aur JA; Simone JV; Verzosa MS; Hustu HO; Pinkel DP; Barker LF
Sangre (Barc); 1978; 23(1):1-12. PubMed ID: 273309
[No Abstract] [Full Text] [Related]
33. Glucose metabolism in children with acute lymphoblastic leukemia treated according to two different L-asparaginase schedules.
Pastore G; Saracco P; Brach del Prever A; Iannacci L; Miniero R; Madon E
Acta Haematol; 1984; 72(6):384-7. PubMed ID: 6442522
[TBL] [Abstract][Full Text] [Related]
34. Glucose Levels Before the Onset of Asparaginase Predicts Transient Hyperglycemia in Children With Acute Lymphoblastic Leukemia.
Gatzioura I; Papakonstantinou E; Dimitriadou M; Kourti M; Sidi V; Triantafyllou P; Koliouskas D; Christoforidis A
Pediatr Blood Cancer; 2016 Jul; 63(7):1181-4. PubMed ID: 27062362
[TBL] [Abstract][Full Text] [Related]
35. Greater decrease of fibrinogen as compared to antithrombin III in L-asparaginase treated leukemia patients.
Vicarioto M; Rosolen A; Cappellato MG; Zanesco L; Girolami A
Folia Haematol Int Mag Klin Morphol Blutforsch; 1986; 113(5):663-9. PubMed ID: 2435632
[TBL] [Abstract][Full Text] [Related]
36. [Treatment with L-asparaginase of renal and testicular involvement in acute lymphoblastic leukemia in children (author's transl)].
Armata J; Cyklis R; Legutko L
Acta Paediatr Belg; 1974; 28(1):49-57. PubMed ID: 4526297
[No Abstract] [Full Text] [Related]
37. Selective deficiency in collagen-induced platelet aggregation during L-asparaginase therapy.
Shapiro RS; Gerrard JM; Ramsay NK; Nesbit ME; Coccia PF; Stoddard SF; Plow EF; White JG; Krivit W
Am J Pediatr Hematol Oncol; 1980; 2(3):207-12. PubMed ID: 6933865
[TBL] [Abstract][Full Text] [Related]
38. [Results of treatment of children with acute lymphatic leukemia (ALL) according to the ALL V protocol of the Netherlands Working Group on Leukemia in Children].
van der Does-van den Berg A; van Wering ER; Suciu S; Solbu G; Rammeloo JA; de Koning J; van Zanen GE
Tijdschr Kindergeneeskd; 1988 Apr; 56(2):61-6. PubMed ID: 3287685
[TBL] [Abstract][Full Text] [Related]
39. Intracranial hemorrhage and focal seizures secondary to use of L-asparaginase during induction therapy of acute lymphocytic leukemia.
Cairo MS; Lazarus K; Gilmore RL; Baehner RL
J Pediatr; 1980 Nov; 97(5):829-33. PubMed ID: 6933231
[TBL] [Abstract][Full Text] [Related]
40. Cyclophosphamide-asparaginase- vincristine-prednisone induction therapy in childhood acute lymphocytic and nonlymphocytic leukemia.
Komp DM; George SL; Falletta J; Land VJ; Starling KA; Humphrey GB; Lowman J
Cancer; 1976 Mar; 37(3):1243-7. PubMed ID: 1063049
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
